Ophthalmic Devices Analysis Report 2024-2032: $10.22 Bn Market by Diagnostic & Monitoring Devices, Surgical Devices, Vision Correction Devices, Application, End User, Regions and Company Landscape – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Ophthalmic Devices Market Report by Diagnostic & Monitoring Devices, Surgical Devices, Vision Correction Devices, Application, End User, Regions and Company Analysis 2024-2032” report has been added to ResearchAndMarkets.com’s offering.


The Ophthalmic Devices Market is projected to reach US$ 10.22 billion by 2032, up from US$ 6.79 billion in 2023, with a promising CAGR of 4.64% from 2024 to 2032.

The global population presents certain challenges associated with demographic changes and elderly people. The global population presents certain challenges associated with demographic changes and an aging population. According to WHO data from 2021, there are over 2.2 billion people worldwide in the geriatric demographic. A global projection of eye health indicates that at least 2 billion people suffer from near or farsighted vision impairment and, going by current findings, nearly half of them could have largely avoided it or have it well controlled.

Ageing is another noteworthy prerequisite for vision-impaired or blind people, of which most are more than 50 years old, therefore meaning there is an increasing demand for LV use. This trend is predicted to support the development of the ophthalmic device market as the number of visually impaired existent ages continually rises; they cover mainly diseases such as cataracts and glaucoma.

The demand for ophthalmic devices is rising due to the increasing prevalence of eye conditions. Lifestyle changes have led to a rapid increase in eye diseases, creating a need for surgical and vision care devices. Factors such as rising per capita income, substantial disposable income, favorable reimbursement policies, and the availability of ophthalmic procedures are contributing to an increase in the number of surgical procedures, thereby driving the demand for ophthalmic devices in the market.

The American Academy of Ophthalmology reports that 81% of Americans know about eye health. Still, many do not recognize glaucoma, age-related macular degeneration, and diabetic eye disease as leading causes of blindness. Additionally, 17.2% of Americans aged 40 and older have been diagnosed with cataracts. This indicates a need for interventions using advanced ophthalmic technologies to monitor and treat common eye conditions effectively.

The latest technological advancements have significantly improved the diagnosis and treatment of ophthalmic disorders. The development of medications, diagnostic devices, laser technology, and surgical techniques has enhanced managing conditions such as cataracts, macular degeneration, glaucoma, and dry eye disease.

Additionally, minimally invasive surgeries like LASIK and multi-wavelength diabetic retinopathy treatment are expected to increase demand for ophthalmic devices. Furthermore, Carl Zeiss Meditec AG’s acquisition of the Dutch Ophthalmic Research Center has expanded its ophthalmic offerings, allowing for comprehensive vision care across various conditions.

North America Ophthalmic Devices Market

The eye care market is projected to have a large market share in North America because of high and increasing disposable income, awareness, a growing population of elder people, and the increasing incidence of eye diseases. As stated by the survey by Statistics Canada in 2021, there are about 7,021,430 uses aged 65 years or older in North America. The eye care market is also expected to have a noticeable market share in North America because of impressive disposable income per capital, increasing awareness, population of seniors, and escalating incidences of eye ailments.

The increased number of elderly people is likely to raise age-related disorders of the eyes; this will naturally lead to increased demand for ophthalmic devices. The National Center for Chronic Disease Prevention and Health Promotion Central revealed that nearly 12 million of the US population older than 40 years are affected by vision impairment and the prevalence is increasing: 1 million people are blind, 3 million have impaired vision after processing the condition, and 8 million people have uncorrected refractive error to cause vision impairment.

More than 21 million individuals in the United States currently have visual impairment including blindness as per BCVA in their better-seeing eye and it is predicted to double within the next three decades. The four common types of conditions that cause vision loss and blindness in the U. S. include diabetic retinopathy, age-related macular degeneration, cataracts, and glaucoma.

Key Attributes:

Report Attribute
Details

No. of Pages
35

Forecast Period
2023 – 2032

Estimated Market Value (USD) in 2023
$6.79 Billion

Forecasted Market Value (USD) by 2032
$10.22 Billion

Compound Annual Growth Rate
4.6%

Regions Covered
Global

Key Players Analysis: Business Overview, Product Portfolio, Sales Analysis, Recent Development & Strategies

Johnson & Johnson

Topcon Corporation

Canon Inc.

Alcon Inc.

STAAR Surgical Co.

GlaukosCorporation

IRIDEX Corporation

Carl Zeiss Meditec AG

Diagnostic & Monitoring Devices – Market breakup in 4 viewpoints

Fundus Camera

Optical Coherence Tomography Scanner

Tonometer Market

Others

Surgical Devices – Market breakup in 4 viewpoints

Refractive Error Surgery Devices

Glaucoma Surgery Devices

Cataract Surgery Devices

Retinal Surgery Devices

Vision Correction Devices- Market breakup in 2 viewpoints

Contact Lenses

Others

Application- Market breakup in 4 viewpoints

Cataract

Vitreo Retinal Disorders

Glaucoma

Refractive Diorders

End User- Market breakup in 3 viewpoints

Hospitals and Eye Clinics

Academic and Research Laboratory

Others

Country – Market breakup of 25 Countries

North America

United States

Canada

Europe

France

Germany

Italy

Spain

United Kingdom

Belgium

Netherlands

Turkey

Asia Pacific

China

Japan

India

South Korea

Thailand

Malaysia

Indonesia

Australia

New Zealand

Latin America

Brazil

Mexico

Argentina

Middle East & Africa

Saudi Arabia

UAE

South Africa

For more information about this report visit https://www.researchandmarkets.com/r/tbw677

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Subscribe on LinkedIn

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Stay up-to-date with the latest Newsletters, free of charge.